Stockreport

Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]

Xenetic Biosciences, Inc.  (XBIO) 
NASDAQ:AMEX Investor Relations: ir.xeneticbio.com
PDF Continued advancement of DNase-based oncology program towards Phase 1 clinical study for the treatment of pancreatic carcinoma and other locally advanced or metastatic [Read more]